Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 2 Study of RiMO-301 for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer
Apply
RiMO-301, Pembrolizumab
Phase 2 Study of RiMO-301 for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step